Impact of Congenital Hyperinsulinism on Trajectories of Neurocognitive Function Across School Age
Impact of Congenital Hyperinsulinism on Trajectories of Neurocognitive Function Across School Age
批准号:
10723317
负责人:
Elizabeth Rosenfeld
金额:
$18.22万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2028-07-31
关键词:
AccelerationAddressAdvisory CommitteesAffectAgeApplications GrantsAwardBiostatistical MethodsBlood GlucoseBrainCharacteristicsChildChildhoodClinicalClinical TrialsCognitionData AnalysesDedicationsDevelopmentDiabetes MellitusDiffuseDiseaseEndocrinologistEnvironmentEpidemiologistEpidemiologyFutureGoalsGrowthHyperinsulinismHypoglycemiaInfantInterventionKnowledgeLifeLiquid substanceLongitudinal StudiesMeasuresMentored Patient-Oriented Research Career Development AwardMentorshipMethodsModelingNeurocognitiveNeurocognitive DeficitOutcomeOutcome AssessmentOutcome MeasurePatient-Focused OutcomesPatternPediatric HospitalsPennsylvaniaPerinatalPersistent Hyperinsulinemia Hypoglycemia of InfancyPhiladelphiaPhysiciansPositioning AttributePrincipal InvestigatorResearchResearch DesignResearch PersonnelResourcesRiskSchool-Age PopulationScientistSocioeconomic StatusStatistical MethodsStressTimeTrainingUnited States National Institutes of HealthUniversitiesVariantWorkagedcareerclinical phenotypeclinical practicecognitive developmentcritical periodexperienceimprovedinnovationlongitudinal designmultidisciplinaryneonatal periodpatient oriented researchpeerprimary outcomeprogramssexskill acquisition
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The overall objective of this K23 application is to provide support for the additional training and experience that
the principal investigator, a pediatric endocrinologist and epidemiologist, needs to develop an independent,
patient-oriented research program in hyperinsulinism. Congenital hyperinsulinism (HI) is the most common
cause of persistent hypoglycemia in infants and children. Onset of hypoglycemia in HI overlaps with a critical
period of neurocognitive development that occurs in the first years of life. While children with HI are more likely
to have neurocognitive deficits, little is known about the factors influencing trajectories of neurocognitive
development in affected children. This project will: (1) identify neurocognitive trajectories in children with HI
employing an accelerated longitudinal design, and (2) examine the relationship between timing of
hypoglycemia exposure and neurocognitive outcomes through comparison of two clinical phenotypes of HI with
natural variation in clinical course. To accomplish these aims a comprehensive neurocognitive battery will be
administered at baseline and repeated at 1- and 2-years after baseline, to school-aged children with cured,
focal HI (hypoglycemia exposure limited to early life), diffuse HI (early life and ongoing hypoglycemia
exposure), and age, sex, and socioeconomic status matched healthy controls. The results of this project will fill
critical gaps in knowledge about the impact of hyperinsulinemic hypoglycemia during periods of marked brain
development and carry significant implications for clinical practice. This study may also have broad implications
for other disorders associated with hyperinsulinemic hypoglycemia, including diabetes mellitus. The principal
investigator will take full advantage of the rich scientific environment and outstanding resources afforded by the
Children’s Hospital of Philadelphia and University of Pennsylvania to achieve her research and training goals.
The proposal includes advanced training in longitudinal data analysis and longitudinal neurocognitive outcome
assessment, which will be achieved through a combination of didactic coursework, practical research
experience, and support form an expert, multidisciplinary mentorship and advisory team. The support of this
K23 will enable the principal investigator to launch a successful career as an independent investigator
dedicated to optimizing neurocognitive outcomes for children with hyperinsulinism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金